(Report ID: 174025) Drug interactions analysis of:
Methylprednisolone Sodium Succinate, Albuterol, Ipratropium BromideMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,583 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 248 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 174025 | Jul, 27, 2006 | 64 | Male |
List of drugs the patient takes:
| Drug |
Methylprednisolone Sodium Succinate |
Albuterol |
Ipratropium Bromide |
| Name |
Asthma |
Condition Aggravated |
Hyperhidrosis |
Sinus Polyp |
Sinus Tachycardia |
Sinusitis |
Results from eHealthMe: 248 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Asthma | 10 (4.03%) |
Condition Aggravated | 22 (8.87%) |
Hyperhidrosis | 2 (0.81%) |
Sinus Polyp | 1 (0.40%) |
Sinus Tachycardia | 23 (9.27%) |
Sinusitis | 3 (1.21%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Drug Ineffective | 3 (21.43%) |
2 | Anaphylactic Shock | 3 (21.43%) |
3 | Renal Failure | 2 (14.29%) |
4 | Renal Tubular Necrosis | 2 (14.29%) |
5 | Pulmonary Haemorrhage | 2 (14.29%) |
6 | Peritoneal Haemorrhage | 2 (14.29%) |
7 | Lactic Acidosis | 2 (14.29%) |
8 | Multi-organ Failure | 2 (14.29%) |
9 | Retroperitoneal Haemorrhage | 2 (14.29%) |
10 | Septic Shock | 2 (14.29%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Solu-medrol | 13 |
2 | Atrovent | 10 |
3 | Isovue-128 | 6 |
4 | Benadryl | 5 |
5 | Lovenox | 4 |
6 | Epinephrine | 4 |
7 | Ventolin | 3 |
8 | Aspirin | 3 |
9 | Tylenol | 3 |
10 | Levaquin | 3 |
Death: 1 (0.40% of total reports)
Cancer: 0
| Name | Count (% of total reports) |
1 | Dyspnoea Nos | 27 (10.89%) |
2 | Sinus Tachycardia | 23 (9.27%) |
3 | Pyrexia | 22 (8.87%) |
4 | Condition Aggravated | 22 (8.87%) |
5 | Pneumonia Nos | 22 (8.87%) |
6 | Sepsis Nos | 21 (8.47%) |
7 | Bronchitis Nos | 19 (7.66%) |
8 | Dehydration | 19 (7.66%) |
9 | Nausea | 18 (7.26%) |
10 | Chest Pain | 18 (7.26%) |
| Name | Count |
1 | Atrovent | 170 |
2 | Solu-medrol | 148 |
3 | Furosemide | 46 |
4 | Nitroglycerin | 40 |
5 | Lasix | 40 |
6 | Levaquin | 40 |
7 | Aspirin | 39 |
8 | Prednisone | 38 |
9 | Folic Acid | 35 |
10 | Levofloxacin | 33 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
